Page 13 - FLIPBOOK
P. 13

• 9 of 11 eligible trials used cisplatin


                                                                                       • N=2492


                                                                                       • 13% reduction in risk of death with
                                                                                           combination chemo


                                                                                       • 5% absolute improvement in 5-yr
                                                                                           overall survival


                                                                                       • NNT 20













                                                                                                     ABC Meta-analysis Collaboration, Lancet 2003
   8   9   10   11   12   13   14   15   16   17   18